Erol Fikrig MD
Waldemar Von Zedtwitz Professor of Medicine (Infectious Diseases) and Professor of Epidemiology (Microbial Diseases) and of Microbial Pathogenesis; Investigator, Howard Hughes Medical Institute; Section Chief, Infectious Diseases

Departments & Organizations
Biological and Biomedical Sciences (BBS): Immunology: Computational Immunology | MicrobiologyYale Medical Group
Global Health Initiative
Microbial Pathogenesis
School of Public Health: Parasitology Program
Skin Diseases Research Center, Yale
Internal Medicine: Infectious Diseases
Molecular Virology
Biography
My laboratory investigates vector-borne diseases. Studies are directed toward understanding Lyme disease, Human granulocytic ehrlichiosis, and West Nile virus. Efforts on Lyme disease include exploring immunity to Borrelia burgdorferi, selective B. burgdorferi gene expression in vivo, and the immunobiology of Lyme arthritis. Human granulocytic ehrlichiosis is caused by a newly described pathogen, transmitted by Ixodes scapularis ticks, that persists within neutrophils. We are investigating the molecular strategies that this pathogen uses to survive in polymorphonuclear leukocytes. West Nile virus can cause fatal encephalitis, and we seek to understand the pathogenesis of this emerging disease. Finally, we are also developing molecular approaches to prevent ticks from feeding on a mammalian host, thereby interfering with pathogen transmission.Education
- BA, Cornell University , 1981
- M.D., Cornell University , 1985
Selected Publication
- Silver, A.C., A. Arjona, W.E. Walker, and E. Fikrig. 2012. The circadian clock controls toll-like receptor 9-mediated innate and adaptive immunity. Immunity 36:251-261. 3315694
Articles

Winter 2008
Lyme disease expert to lead ID section
Erol Fikrig, M.D., FW ’91, an expert in vector-borne diseases and a pioneer in the development of a vaccine for Lyme...

Winter 2008
Richard Belitsky, M.D., James S. Duncan, Ph.D., Erol Fikrig, M.D., Sally Shaywitz, M.D.
Four medical school faculty members have been named to endowed chairs. Richard Belitsky, M.D., deputy dean for...
Fall 1998
Erol Fikrig, M.D.
Erol Fikrig, M.D., associate professor of internal medicine, was a recipient of a $750,000, five-year grant from the...
Winter 2002
A promising vaccine
A vaccine developed by Yale scientists has protected mice from the West Nile virus, a mosquito-borne infection that has...
Summer 2004
Yale scientists identify an early line of defense against West Nile virus
In the five years since the West Nile virus made its first appearance in New York, it has spread to virtually all of...
Winter 2003
From the mouths of ticks
An anti-coagulant protein in the saliva of the deer tick allows it to suck blood from a single wound for days,...
Spring 2000
Antibody test is a reliable screen for ehrlichiosis
A collaboration between scientists at Yale and the State of Connecticut has yielded a simpler and more reliable blood...
Spring 1999
Yale-created Lyme vaccine hits the market
LYMErix, a vaccine against Lyme disease based on Yale research licensed to SmithKline Beecham Pharmaceuticals, received...
Fall 1998
Lyme disease vaccines prove effective
Clinical trials conducted at Yale over the past two years have proven the effectiveness of two Lyme disease...

Spring 2012
Salons bring faculty and students together for wine, books, and conversation
A few days after their return from winter recess, 10 second-year students piled onto a bus in front of the Sterling...



